Addus Homecare Co. (ADUS) Expected to Announce Quarterly Sales of $110.82 Million
Equities analysts predict that Addus Homecare Co. (NASDAQ:ADUS) will announce $110.82 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Addus Homecare’s earnings, with the lowest sales estimate coming in at $110.15 million and the highest estimate coming in at $111.50 million. Addus Homecare reported sales of $103.66 million in the same quarter last year, which indicates a positive year over year growth rate of 6.9%. The firm is expected to issue its next quarterly earnings results on Monday, March 5th.
On average, analysts expect that Addus Homecare will report full year sales of $110.82 million for the current financial year, with estimates ranging from $423.91 million to $425.30 million. For the next year, analysts forecast that the firm will report sales of $453.58 million per share, with estimates ranging from $452.70 million to $454.46 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.04. Addus Homecare had a return on equity of 10.35% and a net margin of 4.30%. The company had revenue of $108.60 million during the quarter, compared to analyst estimates of $108.99 million. During the same quarter last year, the firm posted $0.39 earnings per share. The firm’s revenue was up 4.9% on a year-over-year basis.
Institutional investors and hedge funds have recently bought and sold shares of the business. Nordea Investment Management AB bought a new position in Addus Homecare in the second quarter worth $201,000. First Trust Advisors LP bought a new position in Addus Homecare in the third quarter worth $207,000. Eqis Capital Management Inc. bought a new position in Addus Homecare in the third quarter worth $218,000. The Manufacturers Life Insurance Company increased its holdings in shares of Addus Homecare by 8.5% during the second quarter. The Manufacturers Life Insurance Company now owns 6,614 shares of the company’s stock valued at $246,000 after acquiring an additional 517 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. bought a new position in shares of Addus Homecare during the second quarter valued at $264,000. Institutional investors and hedge funds own 92.97% of the company’s stock.
Shares of Addus Homecare (ADUS) traded down $0.75 during mid-day trading on Monday, reaching $36.90. The company had a trading volume of 26,200 shares, compared to its average volume of 31,744. Addus Homecare has a 12 month low of $29.90 and a 12 month high of $40.75. The stock has a market capitalization of $428.95, a price-to-earnings ratio of 24.12, a price-to-earnings-growth ratio of 1.63 and a beta of 0.17. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.68 and a quick ratio of 2.68.
WARNING: “Addus Homecare Co. (ADUS) Expected to Announce Quarterly Sales of $110.82 Million” was originally published by American Banking News and is the property of of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/15/addus-homecare-co-adus-expected-to-announce-quarterly-sales-of-110-82-million.html.
About Addus Homecare
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.